Medicenna Therapeutics Corp.
(NASDAQ:MDNA)
$0.54
-0.01 (-1.82%)
At Close: 4:00 PM
MDNA Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
MDNA Stock Price Today
Medicenna Therapeutics Corp. (MDNA) stock declined over -1.82% intraday to trade at $0.54 a share on NASDAQ. The stock opened with a loss of -3.64% at $0.53 and touched an intraday high of $0.582, falling -1.82% against the last close of $0.55. The Medicenna Therapeutics Corp. in stock market went to a low of $0.53 during the session.
MDNA Stock Snapshot
$0.55
Prev. Close
49.28 Million
Market Cap
$0.53
Day Low
$0.53
Open
69.64 Million
Number of Shares
$0.582
Day High
-
P/E ratio
-0.16
EPS (TTM)
0.52
Cash Flow per Share
0.42
Free Float in %
0.46
Book Value
149,045
Volume
Contact Details
Company Information
Employees18
Beta0.54
Sales or Revenue-
5Y Sales Change-
Fiscal Year EndsMar. 2022
SectorHealth Care
IndustryBiotechnology
About Company
Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that has completed Phase IIb clinical trial for the treatment of recurrent glioblastoma, as well as preclinical and clinical development stages for the treatment of other brain and non-brain tumors. The company also develops MDNA11, an enhanced version of IL-2 to activate and proliferate the immune cells needed to fight cancer; MDNA209, an IL-2 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host disease; MDNA413, a dual IL-4/IL-13 antagonist to treat cancer immunotherapies; and MDNA132, an IL-13 Superkine for solid tumors. In addition, it provides BiSKITs platform to develop designer Superkines by fusing them to other proteins, antibodies, cytokines, or other Superkines. The company is headquartered in Toronto, Canada.
Frequently Asked Questions
What is the current Medicenna Therapeutics Corp. (MDNA) stock price?
Medicenna Therapeutics Corp. (NASDAQ: MDNA) stock price is $0.54 in the last trading session. During the trading session, MDNA stock reached the peak price of $0.582 while $0.53 was the lowest point it dropped to. The percentage change in MDNA stock occurred in the recent session was -1.82% while the dollar amount for the price change in MDNA stock was -$0.01.
MDNA's industry and sector of operation?
The NASDAQ listed MDNA is part of Biotechnology industry that operates in the broader Health Care sector. Medicenna Therapeutics Corp. , an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases.
Who are the executives of MDNA?
Dr. Fahar Merchant Ph.D.
Founder, Chairman, Pres & Chief Executive Officer
Ms. Elizabeth Williams C.A., CPA, CA, CPA
Chief Financial Officer & Corporation Sec.
Dr. Fahar Merchant Ph.D.
Founder, Chairman, Pres & CEO
Ms. Rosemina Merchant B.Sc., M.E.Sc
Founder, Chief Devel. Officer & Director
How MDNA did perform over past 52-week?
MDNA's closing price is 0.36% higher than its 52-week low of $0.397 where as its distance from 52-week high of $1.88 is -0.71%.
How many employees does MDNA have?
Number of MDNA employees currently stands at 18. MDNA operates from 2 Bloor Street West, 7th Floor, Toronto, ON M4W 3E2, Canada.
Link for MDNA official website?
Official Website of MDNA is: https://www.medicenna.com
How do I contact MDNA?
How many shares of MDNA are traded daily?
MDNA stock volume for the day was 149,045 shares. The average number of MDNA shares traded daily for last 3 months was 117.34 Thousands.
What is the market cap of MDNA currently?
The market value of MDNA currently stands at $49.28 Million with its latest stock price at $0.54 and 69.64 Million of its shares outstanding.